Zetz v. Boston Scientific Corporation

District Court, E.D. California·Decided June 23, 2020·No. 1:19-cv-00451·Unknown

Opinion

8 UNITED STATES DISTRICT COURT 9 EASTERN DISTRICT OF CALIFORNIA 10

11 AUTUMN ZETZ, et al., Case No. 1:19-cv-00451-AWI-SAB

12 Plaintiffs, ORDER ENTERING STIPULATED PROTECTIVE ORDER 13 v. (ECF No. 45) 14 BOSTON SCIENTIFIC CORP., 15 Defendant.

16 17 STIPULATED CONFIDENTIALITY AGREEMENT 18 I. SCOPE OF PROTECTIVE ORDER 19 Plaintiffs Autumn Zetz and Eric Zetz (collectively “Plaintiffs”) and Defendant Boston 20 Scientific Corporation (“Defendant”) hereby enter into the following Stipulated Confidentiality 21 Agreement (“Agreement”) and state as follows: 22 The parties acknowledge that certain documents and information may be sought, 23 produced, or exhibited by and between the parties and non-parties in this proceeding (the 24 “Proceeding”) and that some of these documents may relate to sensitive information which the 25 party or non-party making the production deems confidential in accordance with the rules and 26 standards of the Court. Discovery in this case may involve production of confidential, 27 proprietary, and private information for which special protection from public disclosure and from any purpose other than prosecuting litigation would be warranted. Therefore, it has been agreed 1 by the parties to the Proceeding, through their respective counsel, that to expedite the flow of 2 discovery material and to preserve the confidentiality of certain documents and information, a 3 stipulated confidentiality agreement should be entered. By stipulating to this Agreement, the 4 parties have agreed to be bound by its terms and to request its enforcement by the Court as 5 necessary. 6 II. DISCOVERY PHASE 7 1. This Agreement shall govern all documents and electronically stored information 8 (“ESI”), the information contained therein, and all other information produced or disclosed 9 during the Proceeding whether revealed in a document, deposition, other testimony, discovery 10 response or otherwise, by any party, including any non-party, in this Proceeding (the “Producing 11 Party”) to any other party, including any non-party, when same is designated with the procedures 12 set forth herein. This Agreement is binding upon the parties to the Proceeding, including their 13 respective corporate parents, subsidiaries, and affiliates, as well as their respective attorneys, 14 agents, representatives, officers, and employees and others as set forth in this Agreement. This 15 Agreement is also binding on and applies to all non-parties who either produce or receive 16 documents or information in connection with this Proceeding. 17 2. A Producing Party may designate as “CONFIDENTIAL” any material the 18 producing party believes in good faith constitutes or discloses information or that qualifies for 19 protection pursuant to the Federal Rules of Civil Procedure, specifically information that is trade 20 secret or other confidential research, development, or commercial information, and materials 21 that are deemed confidential under Federal Drug Administration ("FDA") regulations and Health 22 Insurance Portability and Accountability Act ("HIPAA") statutes and/or regulations. 23 3. Confidential information may be further designated as “HIGHLY 24 CONFIDENTIAL” if the Defendant produces materials that it believes in good faith would, if 25 disclosed, cause substantial economic harm to the competitive position of the entity from which 26 the information was obtained because it relates to research and development material on a new 27 product that has not been approved or cleared by the FDA or a similar regulatory body or reflects 1 concerning a current or new product. The Plaintiff will inform the Producing Party of its intent 2 to disclose such information to any individual who is currently, or who at any time during the 3 pendency of this litigation becomes, a consultant to a competitor of the Producing Party in the 4 pelvic mesh business, or is a consultant to an entity actively investigating entering such business, 5 and Plaintiff will follow the procedures for disclosure of such materials to such individual as 6 provided in Paragraph II.8 of this Agreement. 7 4. The designation of “CONFIDENTIAL” or “HIGHLY CONFIDENTIAL” 8 does not include any material, document, or testimony that has been admitted into evidence in 9 any trial without any protections by the trial court. Any document admitted as a trial exhibit or 10 trial testimony for which a trial court has maintained its “CONFIDENTIAL” or “HIGHLY 11 CONFIDENTIAL” designation during trial and that has been sealed or otherwise protected 12 from disclosure by order of the trial court will remain a “CONFIDENTIAL” or “HIGHLY 13 CONFIDENTIAL” absent a separate order of the Court in this matter. 14 5. Challenges to Designations or Redacted Information: Any party may at any time 15 challenge the redaction or the designation of information as CONFIDENTIAL or HIGHLY 16 CONFIDENTIAL to serve a legitimate judicial purpose (e.g., to support a dispositive motion) 17 by providing written notice of its objection to the designating party, or, in the case of a 18 deposition, either on the record at a deposition or in writing later. If, after a timely meet-and- 19 confer process, the parties cannot reach agreement, either the designating party or challenging 20 party may, on reasonable notice, apply for an appropriate ruling from the Court. The disputed 21 material shall continue to be treated as designated, or redacted, until the Court orders otherwise. 22 In any such application concerning a ruling on confidentiality or redacted information, the party 23 claiming the designation of confidentiality or redaction has the burden of establishing that such 24 confidential designation or redaction is proper. 25 6. No person or party subject to this Agreement shall distribute, transmit, or 26 otherwise divulge any material marked CONFIDENTIAL or HIGHLY CONFIDENTIAL, 27 except in accordance with this Agreement. 1 material which is marked CONFIDENTIAL or HIGHLY CONFIDENTIAL, or the contents 2 thereof, may be used by a party, or a party's attorney, expert witness, consultant, or other person 3 to whom disclosure is made, only for the purpose of this action. Nothing contained in this 4 Agreement shall prevent the use of any document, or the contents thereof, at any deposition 5 taken in this litigation. If a party intends to use material that has been marked as HIGHLY 6 CONFIDENTIAL at the deposition of an employee or former employee of a non-producing 7 party in this litigation, then the party shall notify the Producing Party five (5) days in advance of 8 the deposition that it intends to use that category of material. If the parties cannot agree on 9 parameters for usage of the material at the deposition, then the parties will seek the direction of 10 the Court as to the utilization of that category of material in the deposition. 11 8. Access to Confidential Material: If a party or attorney wishes to disclose any 12 document or other material marked CONFIDENTIAL or HIGHLY CONFIDENTIAL, or the 13 contents thereof, to any person retained to work on this action (e.g., expert witness, consultant), 14 the person making the disclosure shall do the following: 15 a. Provide a copy of this Order to the person to whom disclosure is made; 16 b. Inform the person to whom disclosure is made that s/he is bound by this 17 Order; 18 c. Require the person to whom disclosure is made to sign an acknowledgment 19 and receipt of this Order, attached as Exhibit A; 20 d. Instruct the person to whom disclosure is made to return or, in the alternative 21 and with permission of the Producing Party, at the conclusion of this litigation 22 to destroy any document or other material which is marked 23 CONFIDENTIAL or HIGHLY CONFIDENTIAL, including notes or 24 memoranda made from CONFIDENTIAL or HIGHLY CONFIDENTIAL 25 material; 26 e.

Free access — add to your briefcase to read the full text and ask questions with AI

Zetz v. Boston Scientific Corporation, (E.D. Cal. 2020).

Zetz v. Boston Scientific Corporation (Zetz v. Boston Scientific Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Pintos v. PACIFIC CREDITORS ASS'N
605 F.3d 665 (Ninth Circuit, 2010)